ADIPOQ and androgen insensitivity syndrome: Specifically, AIS patients exhibited a median adiponectin level of 16.64 ng/mL with a higher variance, while the control group presented a significantly lower level of 3.78 ng/mL (p-value < 0.001) (Figure 1A).